BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2014 2:59:00 PM | Browse: 1242 | Download: 1006
Publication Name World Journal of Immunology
Manuscript ID 4459
Country/Territory Greece
Received
2013-06-30 10:21
Peer-Review Started
2013-07-01 17:26
To Make the First Decision
2013-07-19 08:26
Return for Revision
2013-07-22 16:58
Revised
2013-08-06 13:30
Second Decision
2013-08-13 11:57
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-08-13 14:00
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-10-23 19:03
Publish the Manuscript Online
2013-11-29 02:07
ISSN 2219-2824 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Probiotics in inflammatory bowel disease: Pathophysiological background and clinical applications
Manuscript Source Invited Manuscript
All Author List Cristiano Pagnini, Gianfranco Delle Fave and Giorgos Bamias
Funding Agency and Grant Number
Corresponding Author Giorgos Bamias, MD, Consultant in Gastroenterology, Academic Department of Gastroenterology, Laikon Hospital, Ethnikon and Kapodistriakon University, 17 Agiou Thoma Street, Athens 11527, Greece. gbamias@gmail.com
Key Words Probiotics; Commensal flora; Mucosa-associated immune system; Inflammatory bowel disease; Clinical trials; Pouchitis; Ulcerative colitis; Crohn’s disease
Core Tip Inflammatory bowel diseases are chronic debilitating diseases of the gastrointestinal tract. Current therapies are not effective in a great proportion of patients and are associated with serious adverse effects. The use of probiotics has been tried as an alternative and safe treatment. Herein, we review the pathophysiological basis for such an application and summarize the data from the major clinical trials.
Publish Date 2013-11-29 02:07
Citation Pagnini C, Delle Fave G, Bamias G. Probiotics in inflammatory bowel disease: Pathophysiological background and clinical applications. World J Immunol 2013; 3(3): 31-43
URL http://www.wjgnet.com/2219-2824/full/v3/i3/31.htm
DOI http://dx.doi.org/10.5411/wji.v3.i3.31
Full Article (PDF) WJI-3-31.pdf
Manuscript File 4459-Review.doc
Answering Reviewers 4459-Answering reviewers.pdf
Copyright License Agreement 4459-Copyright assignment.pdf
Peer-review Report 4459-Peer review.pdf
Scientific Editor Work List 4459-Scientific editor work list.doc